Active not recruitingPhase NA

Acupressure Wristbands for GLP-1RA Related Nausea

Antiemetic Effect of Acupressure Wristbands for GLP-1RA Related Nausea

Lead sponsor

Florencia Ziemke

Asset

GLP-1 / incretin class catch-all

Listed sites

Recruiting sites

Actual enrollment

Study population

Obesity / overweight

Eligibility highlights

Primary endpoint

•Nausea relief

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT06939517

Org study IDSTU25020070_evexiamed

Timeline

Milestones

Study start2024-02-01actual

Primary completion2025-03-13actual

Study completion2025-04-13estimated

Study first posted2025-04-23actual

Last update posted2025-04-23actual

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age18 Years

Maximum age90 Years

SexAll

Healthy volunteersNot accepted

Inclusion criteria

•Adults taking GLp-1RA with nausea

Exclusion criteria

•Adults on GLP-1RA without nausea

•Uncontrolled GERD

•Hx of Gastroparesis

•Other nausea related conditions such as vertigo

•History of chronic use of antiemetic medication for other reasons

Endpoints (2)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Safety / tolerability / PK

Other clinical outcomes

Safety / tolerability / PK

1 endpoint

Primary/protocol endpoint

Nausea relief

Time frame:Nausea relief with use of wristbands for every recorded episode, reviewed weekly, for a total of four weeks

descriptive

Other clinical outcomes

1 endpoint

Secondary/protocol endpoint

Time to onset of relief

Time frame:Time to nausea relief with use of wristbands for every recorded episode, reviewed weekly, for a total of four weeks

time to event, event

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.